These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16649014)

  • 41. Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.
    Vavra KA; Lutz MF; Smythe MA
    Ann Pharmacother; 2010 Apr; 44(4):718-26. PubMed ID: 20233918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
    Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
    Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
    Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
    Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: case report and review of the current literature.
    Heise D; Bräuer A; Quintel M
    J Cardiothorac Surg; 2007 Oct; 2():47. PubMed ID: 17963487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage.
    Rizoli SB; Chughtai T
    Expert Opin Biol Ther; 2006 Jan; 6(1):73-81. PubMed ID: 16370916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005011. PubMed ID: 21328270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.
    Hedner U; Ezban M
    Annu Rev Med; 2008; 59():29-41. PubMed ID: 17845136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant factor VIIa is a pan-hemostatic agent?
    Aledort LM
    Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
    [No Abstract]   [Full Text] [Related]  

  • 50. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Stanworth SJ; Birchall J; Doree CJ; Hyde C
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005011. PubMed ID: 17443565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
    Goodnough LT
    Crit Care Clin; 2012 Jul; 28(3):413-26, vi-vii. PubMed ID: 22713615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful use of recombinant factor Viia in traumatic liver injury--a case report.
    Baranović S; Lubina IZ; Nikolić T; Maldini B
    Coll Antropol; 2011 Mar; 35(1):193-6. PubMed ID: 21661370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recombinant activated factor VII for perioperative bleeding].
    López R; Aeschlimann N; Carvajal C; Lema G
    Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
    Caldwell SH; Chang C; Macik BG
    Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of life-threatening pulmonary bleeding with activated recombinant factor VII.
    Kamphuisen PW; van den Akker JM; Kaasjager KA; Bloemen TI
    Am J Med; 2002 Mar; 112(4):332-3. PubMed ID: 11893382
    [No Abstract]   [Full Text] [Related]  

  • 60. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.